Information  X 
Enter a valid email address

Blancco Tech Grp PLC (BLTG)

  Print          Annual reports

Tuesday 29 September, 2020

Blancco Tech Grp PLC

SHARE ALLOTMENT AND TOTAL VOTING RIGHTS

RNS Number : 4859A
Blancco Technology Group PLC
29 September 2020
 

29 September 2020

 

BLANCCO TECHNOLOGY GROUP PLC

 

(the "Company" or "Blancco")

 

SHARE ALLOTMENT AND TOTAL VOTING RIGHTS

 

 

Blancco Technology Group (AIM: BLTG), the industry standard in data erasure and mobile device diagnostics, announces that today 216,454 Ordinary Shares of 2p each ("the New Ordinary Shares") have been allotted at par in respect of the vesting of an award under the Company's performance share plan. 

 

Application has been made for the New Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will take place on or around 1 October 2020.

 

Following Admission, the New Ordinary Shares will rank equally with the existing Ordinary Shares, the total number of Ordinary Shares in issue will be 75,580,296 and the total number of voting rights will also be 75,580,296. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Group under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information:

Blancco Technology Group plc

 

 

Via Buchanan

Rob Woodward, Chair

Matt Jones, Chief Executive Officer

Adam Moloney, Chief Financial Officer

 

 



Peel Hunt (Nominated Advisor & Joint Broker)

+44 (0) 20 4718 8900

Edward Knight / Nick Prowting / Edward Allsopp

 



Investec Bank plc (Joint Broker)

 

+44 (0) 20 7597 5970

Patrick Robb / Sara Hale / Virginia Bull 

 



Buchanan Communications Limited

Chris Lane / Stephanie Watson / Charlotte Slater

[email protected]hanan.uk.com

 

+44 (0) 20 7466 5000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSLLMATMTTTBBM

a d v e r t i s e m e n t